A newlywed has become the first NHS patient in England with an aggressive form of leukaemia to have a pioneering treatment ...
AVEO Oncology, an LG Chem company, (AVEO) announced today that the first patient has been successfully dosed in a Phase 1b/2 clinical trial evaluating ficlatuzumab in combination with azacitidine and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback